News Releases

All Releases
View Summary OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting
May 22, 2013
PDF 15.1 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
May 2, 2013
PDF 19.1 KB Add to Briefcase
View Summary OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer
May 1, 2013
PDF 13.9 KB Add to Briefcase
View Summary OncoGenex Announces that the Borealis-2™ Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment
Apr 30, 2013
PDF 14.1 KB Add to Briefcase
View Summary OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013
Apr 25, 2013
PDF 9.3 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference
Apr 23, 2013
PDF 8.9 KB Add to Briefcase
View Summary OncoGenex Announces Plans for the Initiation of the Spruce™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Apr 11, 2013
PDF 13.0 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference
Mar 28, 2013
PDF 8.9 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
Mar 7, 2013
PDF 20.1 KB Add to Briefcase
View Summary OncoGenex to Webcast Update on Clinical Development Program and Discussion of Fourth Quarter and Full Year 2012 Financial Results on Thursday, March 7, 2013
Feb 28, 2013
PDF 9.3 KB Add to Briefcase
View Summary OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
Feb 12, 2013
PDF 14.0 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 5, 2013
PDF 9.3 KB Add to Briefcase
View Summary OncoGenex Announces Initiation of Randomized Phase 2 "PACIFIC" Study of OGX-427 in combination with Zytiga® in Men with Metastatic Castrate-Resistant Prostate Cancer
Dec 19, 2012
PDF 12.4 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference
Nov 9, 2012
PDF 8.8 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports Financial Results for Third Quarter 2012
Nov 8, 2012
PDF 20.1 KB Add to Briefcase
View Summary OncoGenex Announces Completion Of Patient Enrollment In Custirsen Phase 3 "SYNERGY" Study
Nov 6, 2012
PDF 11.9 KB Add to Briefcase
View Summary OncoGenex to Webcast Discussion of Third Quarter 2012 Financial Results on Thursday, November 8, 2012
Oct 30, 2012
PDF 10.7 KB Add to Briefcase
View Summary OncoGenex Announces Initiation Of A Phase 3 Trial For Custirsen In Advanced Non-Small Cell Lung Cancer
Sep 27, 2012
PDF 13.7 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Present at Two Upcoming Investor Conferences
Aug 28, 2012
PDF 10.5 KB Add to Briefcase
View Summary OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
Aug 7, 2012
PDF 12.7 KB Add to Briefcase
Showing 81-100 of 385 Page: 1 2 3 4 5 6 7 8 9 ... 20  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase